Get the Stockscreener App
127.75
1.34%
1.69
After Hours:
127.75
Overview
News
Price History
Option Chain
Financials
Why RVTY Down?
Discussions
Forecast
Stock Split
Dividend History
Revvity Inc stock is traded at $127.75, with a volume of 626.15K.
It is up +1.34% in the last 24 hours and up +4.25% over the past month.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
See More
Previous Close:
$126.06
Open:
$125.71
24h Volume:
626.15K
Relative Volume:
0.84
Market Cap:
$15.75B
Revenue:
$2.71B
Net Income/Loss:
$169.43M
P/E Ratio:
21.48
EPS:
5.9463
Net Cash Flow:
$382.96M
1W Performance:
+4.65%
1M Performance:
+4.25%
6M Performance:
+21.67%
1Y Performance:
+15.40%
1-Day Range:
$125.33
$127.81
1-Week Range:
$121.58
$127.91
52-Week Range:
$79.50
$128.15
Revvity Inc Stock (RVTY) Company Profile
Name
Revvity Inc
Sector
Industry
Phone
781-663-5791
Address
940 WINTER STREET, WALTHAM
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-16-24 | Downgrade | UBS | Buy → Neutral |
| Jan-04-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Peer Perform |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-23-23 | Resumed | Goldman | Buy |
View All
Revvity Inc Stock (RVTY) Latest News
The Manufacturers Life Insurance Company Raises Stock Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Canada Pension Plan Investment Board Has $1.40 Million Holdings in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch
Revvity, Inc. (NYSE:RVTY) is Select Equity Group L.P.'s 9th Largest Position - MarketBeat
Armistice Capital LLC Raises Stock Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
How Is Revvity's Stock Performance Compared to Other Diagnostics & Research Stocks? - TradingView
How Is Revvity's Stock Performance Compared To Other Diagnostics & Research Stocks? - Barchart
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Hsbc Holdings PLC Has $18.94 Million Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
A stock that deserves closer examination: Revelation Biosciences Inc (REVB) - US Post News
Revance Therapeutics Shares Fall on Crown Labs Deal Delay - MarketWatch
Financial Fitness Check: Examining Revelation Biosciences Inc (REVB)’s Key Ratios - The Dwinnex
Revance Therapeutics plunges as Crown Labs tender offer delayed amid Teoxane dispute - Seeking Alpha
Barrow Hanley Mewhinney & Strauss LLC Has $46.01 Million Stock Position in Enviri Co. (NYSE:NVRI) - MarketBeat
Merck gains Singapore approval for Winrevair - The Pharma Letter
Independent Franchise Partners LLP Sells 813,672 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Texas Permanent School Fund Corp Acquires 22,540 Shares of Enviri Co. (NYSE:NVRI) - Defense World
Massachusetts Financial Services Co. MA Sells 53,804 Shares of REV Group, Inc. (NYSE:REVG) - Defense World
(RVTY) Pivots Trading Plans and Risk Controls - Stock Traders Daily
King Luther Capital Management Corp Has $20.99 Million Stock Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
(REVG) Technical Data - Stock Traders Daily
Rev group director Charles Dutil sells shares worth over $350k - Investing.com UK
Wall Street analysts’ outlook for Revance Therapeutics Inc (RVNC) - SETE News
Revvity Inc. stock rises Thursday, still underperforms market - MarketWatch
Massachusetts Financial Services Co. MA Reduces Position in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revulva Album Release Tour - Undertheradar
Market Analysts see Revance Therapeutics Inc [RVNC] falling to $9. Time to buy? - The DBT News
An Analysis of Revance Therapeutics Inc (RVNC)’s Potential Price Growth - Knox Daily
Envestnet Asset Management Inc. Has $87.46 Million Position in Relx Plc (NYSE:RELX) - Defense World
Primecap Management Co. CA Has $101.37 Million Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revance Therapeutics (NASDAQ:RVNC) Trading Up 4.7% - MarketBeat
State of New Jersey Common Pension Fund D Sells 24,528 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Crown Labs tender offer for Revance delayed, expect deal to be completedanalyst - MSN
Crown Labs tender offer for Revance delayed, expect deal to be completedanalyst - Seeking Alpha
Federated Hermes Inc. Has $19.93 Million Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
10,598 Shares in Revvity, Inc. (NYSE:RVTY) Acquired by Natixis Advisors LLC - MarketBeat
Revvity's (NYSE:RVTY) investors will be pleased with their favorable 42% return over the last five years - Simply Wall St
Revvity, Inc. (NYSE:RVTY) Receives $126.00 Consensus Price Target from Analysts - MarketBeat
Revvity To Present At Baird Global Healthcare Conference; Webcast At 12:15 PM ET - Nasdaq
Revvity, Inc. (NYSE:RVTY) Shares Bought by TD Asset Management Inc - MarketBeat
Is Revvity, Inc. (NYSE:RVTY) Potentially Undervalued? - Yahoo Finance
Reasons to Retain Revvity Stock in Your Portfolio for Now - MSN
Reasons to Retain Revvity Stock in Your Portfolio for Now - Yahoo Finance
Reasons to Retain Revvity Stock in Your Portfolio for Now - Zacks Investment Research
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Panagora Asset Management Inc. Has $531,000 Stake in Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zurcher Kantonalbank Zurich Cantonalbank Purchases 13,283 Shares of Revvity, Inc. (NYSE:RVTY) - MarketBeat
Revvity Inc. stock rises Friday, still underperforms market - MarketWatch
Revvity Inc Stock (RVTY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
1.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):